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Proteins are fundamental components of all living systems and critical drivers of biological functions. The
large-scale study of proteins, their structures and functions, is defined as proteomics. This systems-wide
analysis leads to a more comprehensive view of the intricate signaling transduction pathways that proteins
engage in and improves the overall understanding of the complex processes supporting the living systems.
Over the last two decades, the development of high-throughput analytical tools, such as microarray technol-
ogies, capable of rapidly analyzing thousands of protein-functioning and protein-interacting events, has
fueled the growth of this important field. Herein, we review themost recent advancements inmicroarray tech-
nologies, with a special focus on peptide microarray, small molecule microarray, and protein microarray.
These technologies have become prominent players in proteomics and have made significant changes to
the landscape of life science and biomedical research. We will elaborate on their performance, advantages,
challenges, and future directions.It’s the Proteins’ World
The completion of the human genome project has revolutionized
the way we think about various diseases, shifting our view
to the gene level. However, in most cases, genes are involved
in the modulation of cellular functions only indirectly, through
products they code for. Thus, the gene products, proteins, which
are involved in virtually every process in the complex and well-
integrated signaling, metabolic, and other cellular networks,
are chiefly responsible for controlling diverse cellular activities
by interacting with their partners specifically and tightly. It is esti-
mated that more than 100,000 proteins exist in the human prote-
ome alone (Pandey and Mann, 2000). This number illustrates
the breathtaking challenge facing the systems-level analysis of
proteins, or proteomics, which aims at deconvoluting the func-
tions of each protein and linking them to specific cellular events.
Compounding the challenge is the fact that the majority of
proteins in the human proteome are also targets of numerous
posttranslational modifications (PTMs), adding another level of
complexity in the protein-interaction network and themodulation
of protein functions (Pflieger et al., 2011). PTMs can significantly
alter the basic properties and functions of proteins and conse-
quently determine the fate of a cell, triggering one pathway
versus another and regulating life/death decisions that a cell
needs to make. It is widely known that deregulation of proteins
can lead to numerous diseases, including cancers, diabetes,
and neurological disorders. This means that proteins represent
a large number of validated drug targets. Thus, the design, dis-
covery, and development of effective drugs that may specifically
turn off functions of target proteins (Schreiber, 2011) have been
of growing interest to both the pharmaceutical industry and
academic laboratories in recent years. The core principle of
drug design is governed by two important criteria: potency and
selectivity. In an ideal scenario, the drug should bind to its targetChemistry & Bproteins with strong affinity and at the same time not introduce
interference to other proteins. The quest for suitable compounds
as drug candidates can be a daunting task with traditional
screening methods. To identify a few biologically active
compounds from the huge libraries of biomolecules is like
searching for a needle in a haystack. Without more sophisticated
screening methods, the process of drug discovery will continue
to consume disproportionately huge amounts of resources and
efforts.
The above-mentioned challenges and obstacles call for high-
throughput screening tools that can significantly accelerate
the drug-discovery process and allow large numbers of pro-
tein-interacting and protein-functioning events to be analyzed
in a rapid and efficient manner. In the last two decades, micro-
array presented itself as a highly viable solution. With this
powerful and robust biotechnology, thousands of distinct bio-
logical moieties, such as DNAs, peptides, small molecules,
and even cells, can be arrayed on a single slide and screened
simultaneously (Uttamchandani et al., 2006; Sun et al., 2006;
Wu et al., 2011a; Foong et al., 2012). Compared to traditional
screening platforms such as microplate-based methods,
microarray technology offers several prominent advantages,
including miniaturization and parallelization. Though the tech-
nology was first introduced as miniaturized DNA assemblies
on chips (Schena et al., 1995), it was not long before further
pioneering efforts made it possible to sequester small mole-
cules, peptides, and proteins in addressable grids (MacBeath
et al., 1999; MacBeath and Schreiber, 2000). Since then, we
have witnessed flourishing development in microarray technol-
ogy and the emergence of various microarray-based platforms,
including peptide, small molecule, and protein microarrays,
which are the subject of this review. Microarray technology
has altered the scope of life science research and enhancediology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 685
Figure 1. Overview of Key Microarray Technologies and Their Applications in the Field Of Proteomics
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tems. Within the field of proteomics alone, microarrays have
been successfully demonstrated for a variety of protein-related
events, including studies of protein expression, interaction,
function, and posttranslational modifications, some of which
will be discussed in detail in the following sections. We will
focus on some of the most noteworthy breakthroughs that
have occurred in the last 2–3 years. All microarray screening
technologies require several steps of operation that are essen-
tial to ensure a high level of performance. Most importantly, the
success of each microarray-based screening heavily depends
on the library construction and microarray fabrication. There-
fore, we will begin by discussing the principles of library
construction and microarray fabrication, providing separate
overviews of various approaches currently employed in these
leading platforms (e.g., peptide, small molecule, and protein
microarrays). We will next discuss recent applications of these
technologies pertaining to proteomics research, with a focus
on three key areas of protein characterizations: functional
annotation, substrate fingerprinting, and ligand/inhibitor binding
(Figure 1). We will summarize some other recent applications
of these platforms in proteomics. We will then conclude our
review by offering our views on outstanding challenges as
well as ways to further advance the microarray technology.
It should be noted that other microarray-based technologies
such as DNA, cell, and tissue microarrays have occasionally
been used in proteomics, but they will not be the subject of
the current review.686 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All righLibrary Construction
As a fundamental and crucial step in microarray screening, the
construction of biomolecule libraries (henceforth referred to
those of peptides, small molecules, and proteins) is also the
most time-consuming phase in the entire microarray process.
Substantial effort is required to ensure successful synthesis of
the library.
Biomolecule libraries can be constructed in two ways. They
can be directly synthesized in situ on the array, or they can be
generated separately and then deposited onto the array. The
earliest example of in situ synthesis was rooted in the form of
SPOT synthesis (Frank, 1992), which provided a facile and
convenient method to create peptide libraries on solid supports
such as cellulose membranes. The method sometimes is
referred to as the ‘‘macroarray’’ in order to draw a clear distinc-
tion from most of the microarray platforms to be discussed in
this review. This membrane-based method does not require
expensive automated instruments and can be performed
expeditiously. In recent years, it has been extended to the
synthesis of other types of synthetic molecules (Frei et al.,
2012). The key advantage of in situ synthesis is the elimination
of the spotting process. It should be noted, however, that the
chemistry utilized for in situ synthesis should be clean and
highly efficient because it will directly affect the quality of the
microarray. In a recently reported strategy, Balakirev and
coworkers constructed a surface-tension small molecule micro-
array in situ to screen the inhibitors of NS3/4A serine protease
of hepatitis C virus (Mugherli et al., 2009). A library of 20,100ts reserved
Figure 2. Representative Examples of Fabrication of Various Biomolecule Libraries
(A) In situ synthesis of the small molecule library on the microarray.
(B) In situ synthesis of the protein microarray through the use of DNA microarray.
(C) Synthesis of the peptide microarray by fragment-based approach.
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tween 200 hydrazides and an aldehyde-containing boronic
acid (Figure 2A). This library was then diluted with DMSO, and
a solution of protease and fluorogenic substrate was applied to
the library via a piezoelectric dispenser to examine the inhibitory
activities. A number of compounds with low micromolar IC50
were discovered through this approach. For example, com-
pound 201: 201(1; see Figure 3) has been identified with a
low IC50 value of 1.5 mM. More recently, the same group has
identified new fluorophores with drug-like property using multi-
component reactions performed in droplet arrays (Burchak
et al., 2011). A total of 1,600 compounds were synthesized
directly on the array by mixing eight heterocyclic amidines,
40 aldehydes, and five isocyanides. Several scaffolds were
identified with fluorescence, and one of the compounds was
found to stain a benzodiazepine receptor in bioimaging experi-
ments. In 2008, He and coworkers described a new approach
to convert DNA arrays to protein arrays in situ (He et al., 2008).
In this approach, cell-free protein synthesis was conducted
with a novel design using a membrane filter sandwiched by
two slides (Figure 2B). Proteins were first synthesized on one
slide, which was arrayed with DNA templates, and then diffused
through the membrane filter and captured on the other slide
coated with capturing agents. This approach has been appliedChemistry & Bto the fabrication of protein microarrays containing a variety of
proteins expressed through cell-free systems, including anti-
body fragments, GFP, and transcription factors.
The othermethod of synthesizing the biomolecule libraries first
and then depositing them robotically onto the glass slide is
clearly more tedious but significantly more robust, and it has
been the main method for the construction of most microarrays.
It also has the advantage that many microarray replicates can be
conveniently fabricated. This helps to save both the cost and
time needed in the subsequent screening process when large
numbers of arrays are required. This approach also boasts a
higher degree of miniaturization and is therefore more econom-
ical when large-scale synthesis is conducted. We shall look at
how different types of biomolecules are constructed using this
method in detail in the following paragraphs.
Peptide Libraries
Peptide libraries represent a very important source for microar-
ray applications due to the well-established solid-phase peptide
synthesis (SPPS; Merrifield, 1985) as well as the comparatively
easy fabrication of the corresponding microarrays. The SPPS
bypasses the tedious synthetic effort normally required for the
preparation of synthetic compounds (e.g., small molecules).
Since its invention in the 1960s, the method has now been
extended to the synthesis of a variety of other compounds,iology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 687
Figure 3. Representative Examples of Small Molecules/Peptides Discovered from Screenings Using Small Molecule and Peptide
Microarrays
Each compound is numbered, followed by its corresponding target protein’s name.
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made in the early 1990s by the introduction of the split-and-
pool synthesis concept (Lam et al., 1991; Furka et al., 1991),
which made it possible to construct large peptide libraries with688 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All righa massive number of molecules in a few short steps. With all of
these arsenals, chemists now have the necessary chemical
tools to make hundreds and even thousands of compounds in
a short time, an essential component for the construction ofts reserved
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be roughly categorized into two subclasses, sometimes without
clear distinction: knowledge-based libraries and combinatorial
libraries. Knowledge-based libraries refer to peptide libraries
constructed using previously known peptide sequences and
are routinely employed to investigate proteins having known
substrates or interacting partners. Common combinatorial con-
cepts such as positional scanning, alanine scanning, and amino
acid deletion can be used to construct knowledge-based pep-
tide libraries. Positional-scanning libraries are constructed by
introducing mutations at specific positions within known binding
sites of the target protein. This type of peptide library is useful to
discover peptide substrates with improved binding activity. In
alanine-scanning libraries, each amino acid in the peptide is
replaced by an alanine residue to probe the contribution of
individual amino acids. To design deletion libraries, the flanking
residues are systematically removed from the parent peptide
to identify the minimum sequence required for activities. Peptide
microarrays made from these libraries have been routinely used
to investigate amino acid residues that are critical to molecular
interactions (Uttamchandani et al., 2003). Microarrays made of
combinatorial peptide libraries, on the other hand, can be more
appropriate if the substrate or binding partner of the target pro-
tein is unknown. In principle, either semirandom or completely
random peptide libraries may be constructed. In practice, the
semirandom combinatorial approach is usually carried out in
order to minimize the number of peptides needed to be synthe-
sized, and this is done by introducing a series of amino acid
building blocks at randomized positions while holding several
previously defined amino acid positions fixed. The method can
be used to study unknown proteins and identify new peptide
substrates/ligands. It also enables a more comprehensive study
of protein-peptide interactions. In a recent example, we intro-
duced what we called a fragment-based peptide microarray
based on this concept to investigate the substrate specificities
of seven 14-3-3 proteins (Lu et al., 2008). 14-3-3 proteins are
phosphoserine/phosphothreonine (pS/T) binding proteins that
interact with numerous cellular proteins and regulate a variety
of protein-interacting events. In order to minimize the number
of peptide spots and allow sufficient sequence coverage in a
heptapeptide, P-3P-2P-1pS/TP+1P+2P+3, the two fragments flank-
ing each side of pS/T were replaced, one at a time, by degener-
ated peptide sequences (Figure 2C). By ‘‘scanning’’ fragments
(that is, the tripeptides flanking pS/T) rather than positions,
these combinatorial libraries retained the ‘‘neighboring-position
effect’’ associated with protein-peptide interactions. Several
highly selective peptides were identified and further validated.
Results from these experiments showed that this kind of peptide
microarrays is effective in identifying both known and unknown
protein-peptide interactions. The same concept was recently
extended to the fabrication of a peptide-small molecule hybrid
array (Wu et al., 2010).
Small Molecule Libraries
With their diverse biological properties, small molecule libraries
provide another rich source for microarray screening. Small
molecule arrays are powerful platforms for discovering new pro-
tein/small molecule interactions, which will potentially generate
lead compounds for drug discovery. By arraying thousands of
distinct small molecules on a single slide, the potency and selec-Chemistry & Btivity of small molecule ligands against target proteins can be
rapidly evaluated. Several synthetic methods, such as diver-
sity-oriented synthesis (DOS) and fragment-based approaches,
have been developed over the years to facilitate synthesis
of small molecule libraries. DOS dramatically facilitates the
construction of small molecule libraries with both skeletal
and stereochemical diversity (Schreiber, 2000). For instance, a
3,780-member small molecule library was constructed by
Schreiber’s group using a DOS approach (Kuruvilla et al.,
2002). The small molecule library shared a common 1,3-dioxane
scaffold, which could be synthesized in a stereoselective
manner. Upon completion of the synthesis, small molecules
could be released from the solid support and anchored cova-
lently onto array. One small molecule identified from array, which
was later named uretupamine A (2; Figure 3), was found to inhibit
Ure2p selectively in a physiological environment. This and other
similar DOS-based small molecule microarrays have been used
to screen a number of interesting protein targets (haptamide B,
3, as a Hap3p binder; Figure 3) (Koehler et al., 2003; Barnes-
Seeman et al., 2003), some of which will be further elaborated
in the following paragraphs.
Protein Libraries
In general, proteins tend to be more fragile and delicate when
compared to peptides and small molecules. Consequently,
fabricating a protein library has proven to be much more com-
plex and time-consuming. The first proteome array was gener-
ated by Snyder and coworkers in the form of a yeast proteome
array. The group cloned and expressed 5,800 yeast proteins
from 6,200 yeast open reading frames with an oligohistidine
tag and subsequently anchored them to nickel-coated slides to
perform global proteome analysis (Zhu et al., 2001). With this
setup, the group made the first demonstration that novel
calmodulin- and phospholipid-interacting proteins can be readily
identified from the fabricated proteome array. Later, the same
group used this proteome array to carry out large-scale analysis
of protein phosphorylation in yeast (Ptacek et al., 2005). Over
4,000 phosphorylation events with 1,325 different proteins
have been identified. Novel regulatory modules were discovered
by integrating the massive amount of data obtained from
different protein-associated events, including protein phosphor-
ylation, protein-protein interaction, and protein-DNA binding.
This yeast proteome array, as well as similar proteome array
spotted with human proteins, has been commercially available
(http://www.invitrogen.com) for several years.
Caveats of Each Type of Library
The construction of peptide libraries is comparatively easier
than other types of libraries, and the yield of peptide libraries is
much higher than that of small molecule libraries. Because of
this, peptide microarrays remain the most popular and effective
tools in academic laboratories for large-scale analysis of protein
functions and interactions. The information on substrate/ligand
specificity derived from peptide microarray data can help to
predict physiologically relevant protein-interacting partners and
provide useful information for inhibitor design. The interaction
between selected peptide sequences and screened proteins,
however, may not truly reflect the interactions under physio-
logical conditions. The synthesis of small molecule libraries
is not as straightforward as peptide libraries. The synthetic
route of small molecule libraries needs to be carefully devisediology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 689
Table 1. Various Immobilization Methods Developed for
Microarray Fabrication
Immobilization
Methods Peptides
Small
Molecules Proteins
Noncovalent biotin/avidin fluorous/
fluorous
His tag/Ni-NTA
DNA/DNA biotin/avidin ZR/ZE domain
DNA/PNA GST/anti-GST
DNA/DNA
Random
covalent
amine/NHS photocrosslink amine/NHS
amine/epoxy isocyanate/
various
amine/epoxy
amine/
aldehyde
silyl chloride/
alcohol
amine/
aldehyde
Site-specific
covalent
Diels-alder staudinger
ligation
native chemical
ligation
native chemical
ligation
glyoxylyl/
aminoxyl
click chemistry
Staudinger
ligation
tetrazine/
dienophile
staudinger
ligation
glyoxylyl/
semicarbazide
thiol/quinone
methide
oxime ligation
thiol-ene
A detailed discussion of different immobilization methods for the three
types of microarray can be found in previous reviews (Wu et al., 2011a;
Foong et al., 2012). GST, glutathione S-transferase; Ni-NTA, nickel-
nitrilotriacetic acid; PNA, peptide nucleic acid.
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and yield at the end of the synthesis. Stereoselectivity is one of
the critical factors to be accounted for during the design of small
molecule libraries, as most chiral small molecules can only bind
to their intended biological targets with their correct stereoiso-
mers. It poses a substantial challenge for synthetic chemists to
design stereoselective reactions that are compatible with solid-
phase synthesis. Finally, although protein microarrays have pre-
sented themselves as powerful and versatile tools for large-scale
proteomic studies, the production of large collections of func-
tional proteins with high purity is still prohibitively expensive
and not easily achievable in most academic laboratories at the
moment. A number of questions still need to be carefully ad-
dressed when carrying out protein microarray research, such
as whether the proteins still retain their functions on the array af-
ter expression, whether the proteins are functional only when
they are in a complex form, and which specific posttranslational
modification the proteins carry. Most large-scale productions of
proteins needed in a protein microarray thus far do not suffi-
ciently address these critical issues, making data generated
from the resulting platform significantly less meaningful than
promised.
Microarray Immobilization
Unlike in situ synthesized microarrays, on which biomolecules
are immobilized while they are being synthesized on the array,
spotted microarrays need a requisite microarray immobilization
step upon completion of library synthesis. This is done by
depositing biomolecules in small droplets onto suitable surfaces690 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All righusing a robotic dispensing system. Depending on the immobili-
zation strategy used, the molecules can be linked to slides cova-
lently or noncovalently. Immobilization methods are at the heart
of most microarray technologies and can significantly affect the
quality of downstream microarray screening. Several factors
need to be considered when deciding on a suitable immobiliza-
tion strategy (i.e., molecular orientation, linkage chemistry, and
stability of the biomolecules). Numerous immobilizationmethods
have been developed in recent years and have been extensively
discussed in our previous reviews (Wu et al., 2011a; Foong et al.,
2012). We have summarized these key methods in Table 1
according to the types of biomolecules. The methods can be
broadly classified into three types: noncovalent immobilization,
random covalent immobilization, and site-specific immobili-
zation. In the following sections, we will briefly discuss each
method with a focus on the most recent publications.
Noncovalent Immobilization
A number of noncovalent interactions have been successfully
applied to biomolecule immobilization (Table 1). For instance,
DNA-DNA interaction was used in an approach developed by
Niemeyer and coworkers (Schroeder et al., 2007). In this setup,
several biotinylated peptides were first conjugated with strepta-
vidin-DNA complexes. They were then hybridized onto a DNA
array through interaction with the complementary DNA strands.
Utilizing fluorous interactions, Schreiber’s group constructed
a small molecule library with a fluorous tag and anchored
the small molecules onto array to screen potent inhibitors of
the HDAc protein family (Vegas et al., 2007). Recently, Jeon
and coworkers have developed a fluorescent tag system by
combining fluorous interaction and a coumarin fluorophore tag.
The design allows for the evaluation of microarray fabrication
in a stepwise manner through fluorescence detection (Jeon
et al., 2012). Valles-Miret and Bradley (2011) devised a novel
approach by combining a fluorous tag and photochemistry to
immobilize anygiven compound. In thismethod, fluorous-tagged
diazirines were first immobilized onto fluorous slides before
small molecules were printed at the same position (Figure 4A).
UV irradiation was then applied to generate highly reactive
carbene species to covalently link small molecules to the slide.
Random Covalent Immobilization
In covalent immobilization, the linkage formed between biomol-
ecules and the slide surface is more stable and robust than that
formed by noncovalent interactions. This will, in principle, lead
to higher resistance to harsh wash conditions. Commercially
available epoxy-, aldehyde-, and N-hydroxysuccinimide (NHS)-
coated slides are often used for immobilization of biomolecules
containing amines and other nucleophilic groups present in
biomolecules. It should be noted, however, that biomolecules
immobilized by these random covalent methods, due to multiple
reactive groups on their surfaces, may possess multiple orienta-
tions, resulting in nonhomogeneous immobilization and loss of
molecular recognition. This is especially true for proteins and
peptides. Small molecules can be immobilized by random cova-
lent methods as well. For example, Schreiber and coworkers
developed several immobilization chemistries, including silyl
chloride/alcohol as well as diazobenzyldiene/phenol and acidic
compounds, to covalently anchor small molecules synthesized
from DOS methods onto microarrays. Recently, the team has
successfully applied isocynanate chemistry to capture smallts reserved
Figure 4. Selected Examples of Immobilization Strategy in Microarray Fabrication
(A) Small molecule immobilization by combining fluorous interaction and photochemistry.
(B) Small molecule immobilization by photochemistry between thiol and quinone methide.
(C) Small molecule immobilization through a reaction between tetrazine and dienophile.
(D) Protein immobilization by combining oxime ligation and EPL strategy.
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hols, amines, carboxylic acids, thiols, and phenols (Bradner
et al., 2006). Park and coworkers immobilized a small molecule
library onto an isocyanate-functionalized slide with pyridine
vapor activation (Lee and Park, 2011). The group was able toChemistry & Bidentify 2,4,40-trihydroxychalcone (4; Figure 3) as a novel binder
of tyrosinase (Kd = 0.4 mM). The group also found that the
slides coated with poly(propyleneoxide) amine (Jeffamine)
displayed a higher signal-to-noise ratio compared with slides
functionalized by other molecules.iology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 691
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This represents an important advance in microarray fabrication
as it allows biomolecules to display in uniform orientations,
thereby facilitating molecular recognition. Site-specific immobi-
lization is usually conducted by introducing a unique tag into
the biomolecule (Lesaicherre et al., 2002). The biomolecule
can then be anchored to slides precoated with appropriate
functional groups. A number of classical reactions have been
applied by different research groups to immobilize various
biomolecules onto arrays, including Diels-Alder reaction,
Staudinger ligation, thiol-ene chemistry, native chemical ligation,
and others (Table 1). Recently, Arumugam and Popik (2012)
developed a reversible light-directed approach for surface func-
tionalization and patterning. This small molecule immobilization
strategy is based on photochemistry between thiol and quinone
methide (Figure 4B). In this approach, the surface was first pho-
tobiotinylated with 3-(hydroxymethyl)-2-naphthol-biotin. It was
then stained with a fluorescently labeled avidin. The group found
that the thioether linkage was stable under normal conditions.
Under UV irradiation, it could be cleaved and regenerate a free
thiol molecule. In another recent example, Wittmann and co-
workers proved that dienophile-containing carbohydrates could
be covalently linked to tetrazine-derivatized slides (Beckmann
et al., 2012). To immobilize unfunctionalized carbohydrates,
the group devised a bifunctional linker to install a dienophile
tag onto carbohydrates through oxime reaction. The carbohy-
drates with the dienophile tag can subsequently be anchored
onto tetrazine-modified slides directly (Figure 4C). The immobili-
zation method was proven to be homogeneous and superior to
previous amine- and thiol-basedmethods. Site-specific immobi-
lization of proteins is never a trivial task because proteins are
fragile andmay easily lose their activity during the immobilization
process. Waldmann and coworkers have recently developed a
new strategy based on oxime ligation for site-specific labeling
of proteins (Yi et al., 2010). The reaction between oxyamine
and ketone is highly specific and efficient. In this approach, a
protein was first generated with C-terminal oxyamine through
thiolysis of an intein fusion protein. The protein-ONH2 generated
could then react with a ketone-containing fluorophore by oxime
ligation. The reaction was shown to be very mild as the protein
retained excellent activity after labeling. The group subsequently
extended the approach to dual-color labeling and site-specific
microarray immobilization of proteins (Yi et al., 2011, 2012)
(Figure 4D).
Caveats of Each Type of Immobilization Approaches
Each of these immobilization approaches has its own pros and
cons. For example, the DNA-mediated strategy can take advan-
tage of convenient deconvolution techniques using DNA array.
However, it requires extra synthetic steps to incorporate a
DNA tag into the target molecule. A general consensus for the
noncovalent immobilization approach is that noncovalent
interactions may not be strong enough to survive subsequent
screening procedures. The random covalent immobilization
method has provided a convenient approach for microarray
immobilization without introducing a specific tag in themolecule.
It helps to relieve time and effort during library synthesis. How-
ever, it should be noted that biomolecules immobilized using
this approach may adopt different orientations on the array,
and this may result in loss of protein recognition. In particular,692 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All righwith the photoimmobilization approach, some key interacting
groups of small molecules may react with molecular handles
on slide surface. The binding site for proteins may therefore be
blocked. Site-specific immobilization has undoubtedly provided
the most effective approach for biomolecule immobilization.
The disadvantage of this approach is that considerable efforts
are required to introduce a specific chemical tag to the target
molecule during synthesis. This is especially notable in the
case of protein immobilization. Nevertheless, the inconvenience
of introducing a special tag is paid off by retaining the biological
activity of the proteins.
Microarray Application
In the last decade alone, microarrays have evolved from being
used primarily as basic analytical research tools into now viable
options for more sophisticated applications in proteomics,
including protein expression profiling, molecular interaction
mapping, biomarker and drug discovery, disease diagnosis,
and vaccine development. In this section, we will elaborate on
recent studies of microarray applications that focus primarily
on three areas most relevant to proteomic research, namely
functional annotation, substrate fingerprinting, and ligand/
inhibitor binding, with each application taking full advantage of
a microarray’s key features: miniaturization and parallelization.
Functional Annotation
With conventional protein screening assays, the functional
annotation of proteins is usually performed by incubating them
with appropriate substrates, which will report protein activities
in the form of absorbance, fluorescence, or luminescence
signals. Almost a decade ago, the first microarray-based
strategy for rapid and reliable functional annotation of proteins
was developed (Chen et al., 2003). The approach uses fluores-
cently labeled activity-based probes, which detect correspond-
ing enzymes based on their intrinsic enzymatic activity via the
formation of covalent probe-enzyme complexes. In a proof-of-
concept experiment, a total of 12 proteins were immobilized
onto epoxy-functionalized slides and screened with a panel of
different activity-based probes. The results provided clear evi-
dence that the proteins were successfully detected on the basis
of their enzymatic activity. At the next stage, this strategy was
extended to profile proteases with a panel of activity-based
probes by virtue of enzymatic activities and substrate specific-
ities (Srinivasan et al., 2006; Uttamchandani et al., 2007a). These
reports laid the groundwork for potential high-throughput
screening of enzymatic activities and inhibition in a protein
microarray. Eppinger and coworkers made use of the same
strategy to quantitatively determine enzyme kinetics on a
microarray (Eppinger et al., 2004). By immobilizing papain
(a well-known cysteine protease) on hydrogel slides and incu-
bating it with a fluorescently labeled suicide inhibitor, these re-
searchers were able to obtain kinetic information of the enzyme
directly from the resulting microarray data. The strategy was
subsequently extended to the study of six cathepsins against
seven inhibitors (Funeriu et al., 2005) to obtain the corresponding
inhibition constants that were later shown to be consistent with
previously reported data. Recently, Jung and coworkers have
developed a new surface-concentration-based assay for quanti-
tative kinetic analysis of proteases on microarray (Jung et al.,
2012). In this method, a series of peptides with rhodaminets reserved
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quantitative kinetic data such as Michaelis constant (Km)
and maximum velocity (Vmax) using dry-off measurements.
By integrating an activity-based probe and an antibody micro-
array, Cravatt and coworkers took an alternative approach to
design a novel microarray platform that enables proteomic
profiling of enzyme activities (Sieber et al., 2004); a proteome
was first incubated with probes. The labeled enzymes were
then captured and anchored onto the antibody microarray
to identify the specific enzyme (Figure 5A). Compared with
traditional gel-based methods, the array-based method mini-
mized the consumption of expensive reagents and improved
the sensitivity to detect enzymes. It should be noted that high-
quality antibodies were required for the successful implementa-
tion of this approach.
The application of microarray technology has also been
extended to the study of functional protein pathways. Lackner
and coworkers developed a reverse-phase protein array to
analyze the phosphorylation status of 100 proteins with different
breast cancer cell lines (Boyd et al., 2008). Cellular lysates from
different cell lines were spotted onto the slide in serial dilutions
and probed with various antibodies that recognize phos-
phorylated proteins. The study allowed the group to carry out
signaling pathway network analysis and classify breast cancer
cell lines into different subtypes. Furthermore, microarray anal-
ysis can also yield valuable information on the deregulated
signaling pathway in individual cancers.
Substrate Fingerprinting
One of the main applications of microarray in proteomics is to
map ligand binding specificities of a protein, which is essential
to understand the protein’s physiological role and interactions.
For enzymes in particular, information about their substrate
specificity is extremely critical for a better understanding of
their many cellular functions. A comprehensive knowledge of
enzyme substrate specificity can also help in the successful
design of highly potent and selective inhibitors, ultimately
facilitating the drug-discovery process.
Histone peptide microarray has recently become a popular
and effective tool in epigenetic research. Epigenetic modifica-
tions can have a profound influence on a variety of human
diseases. In a recent example, Mrksich and coworkers synthe-
sized a peptide library to investigate the substrate specificities
of various lysine deacetylases (Gurard-Levin et al., 2010). The
level of deacetylation was analyzed by label-free analysis, in
this case MALDI mass spectrometry. The researchers demon-
strated that this analytical design was effective in detecting the
deacetylation activity of crude cellular lysates and monitoring
the changes in the enzymatic activity during the different cell
cycles. Arrowsmith and coworkers constructed a position-scan-
ning peptide library on cellulose membrane (a macroarray)
based on two histone peptides, H3K9me3 (histone 3 trimethyl
lysine 9) and H3K27me3 (histone 3 trimethyl lysine 27), to profile
the substrate specificities of chromodomains (Kaustov et al.,
2011). In a more recent work by Knapp and coworkers, the
researchers synthesized a library of peptides containing all
acetylated lysine (Kac) sites from histone proteins on cellulose
membranes and investigated the binding preferences of 43
different bromodomains (Filippakopoulos et al., 2012). This
study led to the identification of 485 new protein-histone inter-Chemistry & Bactions, a number of which were further confirmed by isothermal
titration calorimetry. Notably, the study revealed that PTMs
could exert significant influence on peptide/bromodomain
interactions.
Research on substrate specificity of kinases is another area
of active investigation that has been ongoing since the early
2000s. In a more recent study, a microarray containing 290 Tyr
peptides and 1,100 Ser/Thr peptides was constructed and
used to investigate the substrate specificity of several kinases
(Han et al., 2010). With this approach, the group not only
confirmed previously identified kinase-recognizing motifs but
also uncovered many new sequences with high potency and
selectivity. This high-density peptide array approach can provide
a robust tool to facilitate the discovery of potential substrates
of other kinases in a high-throughput and sensitive manner.
Our group hasmade some recent progress in this field by con-
structing a phosphopeptide array to profile various SH2 domains
(Gao et al., 2012). Previous phosphopeptide microarrays had
primarily focused on profiling enzymatic activities of different
protein phosphatases (Ko¨hn et al., 2007; Sun et al., 2008). In
this new study, high-affinity, selective peptides designed for
individual SH2 domains were first identified from microarray
and then examined by pull-down experiments. It was found
that peptides identified from the peptide microarray were able
to successfully pull down target proteins directly from crude
cellular lysates. Cellular profiling experiments with different cell
lines revealed potential cancer-selective peptides. Further
pull-down experiments with these peptide hits led to the iden-
tification of three potential cancer biomarkers, highlighting
the feasibility of this microarray strategy to facilitate future
biomarker discovery.
Computational prediction methods have also been integrated
into peptide array for proteome-wide profiling of substrate spec-
ificity of proteins. Denu and coworkers utilized SPOT array to
screen SIRT3 binders from both known and potential peptide
substrates (Smith et al., 2011). Based on the array results, they
developed a machine-learning method to establish binding
trends and predict new binding sequences from the mitochon-
dria proteome. Results from this experiment indicated that
SIRT3s are involved in several metabolic pathways and new
enzyme/substrate interactions could be discovered. In 2012,
Wang and coworkers combined computer modeling and bioin-
formatics analysis to filter around 700 potential binders of the
Abl1 SH3 domain (Xu et al., 2012). These predicted peptides
were synthesized, printed onto a microarray, and used to inves-
tigate their binding specificities against the Abl1 SH3 domain
(Figure 5B). The study indicated for the first time that the Abl1
SH3 domain may interact with numerous methyltransferases
and RNA-splicing proteins. This strategy may offer a practical
pathway to detect novel protein interactions through domain-
peptide recognition events.
Ligand/Inhibitor Binding
Small molecule microarrays are powerful tools to identify
potential binders of proteins. Under standard operational pro-
cedures, proteins can be labeled with a fluorescent dye (e.g.,
Cy3 or Cy5) and then incubated with an array of small molecules.
Excessive fluorescent dye can be washed away. The detected
fluorescent intensity can be used as a guide to identify the small
molecule binders of the proteins. A reference protein can beiology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 693
Figure 5. Recent Examples of Microarray Applications in Proteomics
(A) A functional annotation of proteins by integrating the antibody array and activity-based probes.
(B) Substrate fingerprinting of the SH3 domain by integrating the computational method and peptide array.
(legend continued on next page)
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cross-activity. From such results, highly specific and strong
small molecule binders of a target protein could be rapidly iden-
tified. It should be noted that random dye-labeling methods
may interfere with protein function and sometimes can even
lead to the denaturation of proteins. To alleviate this problem,
several groups have employed a site-directed strategy to
introduce fluorophores to proteins through genetically encoded
fluorescent tags or affinity tags coupled to dye (Kawahashi
et al., 2003; Hurst et al., 2009).
Apart from lead discovery, another important application of
small moleculemicroarray is to generate useful chemical probes,
as compounds identified from small molecule microarray
screening can be directly converted to chemical probes by
simply replacing their immobilization handle with a fluorescent
tag without the loss of their activity (Shi et al., 2009). Chemical
probes are versatile tools that can help researchers to under-
stand biological functions and the roles of proteins in diseases.
Designing and discovering selective chemical probes for a given
therapeutic protein has become a highly active research topic in
recent years.
Schreiber and coworkers were among the first groups to
develop small molecule microarrays for ligand discovery. With
their DOS strategy, several small molecule microarrays were
successfully fabricated in the early 2000s. For example, a small
molecule microarray with 18,000 compounds was constructed
and screened against the protein calmodulin for potential
binders (Wong et al., 2004). One of the compounds identified
(5; Figure 3) could induce cardiovascular malfunction in a zebra-
fish phenotypic assay. Recently, the group has anchored more
than 15,000 small molecules from a variety of sources onto an
array and studied the binding affinity of 100 different proteins
(Clemons et al., 2010). It was found that increasing the content
of sp3-hybridized and stereogenic atoms in the compound
library in general improves the protein-binding selectivity of
library members. This finding could yield instrumental informa-
tion in the future design of compound collections with improved
biological activities. By integrating small molecule and peptide
hybrid libraries and microarray technology, our group took
a different approach to uncover small molecule inhibitors of
14-3-3s (Wu et al., 2010). In this setup, the two flanking peptide
fragments of pS residue (RFRpSYPP) were replaced by a library
of commercially available acid and amine building blocks,
respectively. A 243-member N-terminal library and a 50-member
C-terminal hybrid library were synthesized and anchored onto
the array to screen for potent binders of 14-3-3s. After potent
binders from each sublibrary were positively identified, the
‘‘hits’’ amine and acid building blocks were reconstituted to
yield the final nonpeptide small molecule inhibitors (Figure 5C).
One of the most potent inhibitors identified, 2–5 (6; Figure 3),
was further tested in cell-based assays and was shown to
possess good cell permeability and be capable of inducing
apoptosis and cell-cycle arrest of cancer cells. This example
underscores the importance of creative compound library(C) A ligand binding study of the small molecule array using a fragment-based a
(D) The peptide microarray was fabricated to profile peptide/RNA interactions.
(E) The small molecule array was constructed to study the binding specificity of
(F) The polymer-glycan array was constructed to profile various lectins.
Chemistry & Bdesign in microarray generation in order to yield novel small
molecules with interesting biological activities.
Recently, our group constructed a 270-member peptide
aldehyde array to investigate the binding specificities of various
cysteine proteases in crude lysates (Wu et al., 2011b). We
were able to obtain distinct binding profiles by screening the
platform first with fluorescently labeled recombinant proteases.
We then moved ahead to test the microarray directly with crude
proteome lysates prepared from apoptotic HeLa cells and red
blood cells (RBCs) infected with the parasite Plasmodium
falciparum. Characteristic microarray binding profiles were
observed in the study, and they were shown to be directly
linked to the endogenous enzymatic activities of cysteine pro-
teases present in both lysates. By screening the RBC-infected
cellular lysates further with the platform, we were able to
successfully obtain highly distinctive microarray ‘‘fingerprints’’
that differentiate various stages of the parasitic infection. In a
further study, the hit-identified ARFK-CHO (7; Figure 3) from
the array was converted into a chemical probe containing a
biotin handle. Several cathepsin proteases were identified in
the subsequent pull-down experiment using this chemical
probe, again demonstrating the capability of peptide and
small molecule microarrays for biomarker discovery. In a
more recent work, a small molecule microarray immobilized
with 105 aldehyde-containing compounds was screened with
mammalian cell lysates overexpressing cathepsin L (Na et al.,
2012). Two potent inhibitors, namely D02 (8; Figure 3) and
D17 (9; Figure 3), were discovered from the microarray
screening. The inhibitors were later converted to cell-perme-
able small molecule probes that were used to monitor
enzymatic activities in live mammalian cells. The examples
summarized herein clearly demonstrate that microarray tech-
nology can provide an innovative and rapid approach to the
future development of chemical probes.
Other Applications
Apart from the three key groups of proteomic applications
mentioned in the previous sections, microarray technology has
found other novel applications in several recent examples, which
we will summarize in the following paragraphs.
In a very recent expansion of microarray applications, Shin
and coworkers developed a peptide array for rapid profiling of
peptide-RNA interactions (Pai et al., 2012). A series of peptides
were designed based on an amphiphilic peptide, which was pre-
viously known to bind strongly to hairpin RNAs. Upon synthesis
and immobilization (using an epoxy-modified glass slide), the
corresponding peptide microarray was used to screen against
six fluorescently labeled hairpin RNAs (Figure 5D). It was re-
vealed that the binding affinity of the peptides was determined
by the sequence and the shape of the RNA. A minimum of 14
amino acid residues were required for the peptides to bind to
the RNA tightly. Interestingly, one of the peptides identified
was capable of inhibiting TAR-Tat interactions in cells. The strat-
egy offers a promising tool to produce peptide-based probes for
functional annotation of RNAs in cells.pproach.
amyloid peptide.
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a high-density overlapping peptide array to map interleukin-13
(IL-13) binding sequence on its receptors (Madala et al., 2011).
IL-13 is a cytokine involved in the pathogenesis of allergen-
induced asthma. The peptide sequences are derived from two
IL-13 receptors, namely IL-13Ra1 and IL-13Ra2. All the peptides
consist of 15 amino acid residues, and each of these peptides is
selected by shifting three amino acids along the sequence of
extracellular domains of receptors. By combining molecular
docking and a peptide microarray strategy, the group revealed
structural differences between the receptors and successfully
generated a receptor-specific antibody of IL-13Ra1.
Hecht and coworkers devised a small molecule microarray
to identify amyloid peptide binders (Chen et al., 2010). In this
design, a total of 17,905 compounds from various sources,
including natural product, commercial compound collections,
and DOS library, were immobilized onto slides and screened
with fluorescently labeled amyloid peptides (Figure 5E). A total
of 79 hits were identified from array experiments and further
incubated with PC12 cells to examine their inhibiting activity on
amyloid peptide-induced cytotoxicity. One of the identified hits
(10; Figure 3) was found to enhance fibril formation and unravel
a possible novel rescue mechanism without the formation
of an early toxic oligomer. The strategy described here may
generate useful therapeutic leads to reduce amyloid peptide
toxicity and ultimately prevent Alzheimer’s disease.
Carbohydrate microarray, a subtype of small molecule micro-
array, is another field that has been actively pursued. Its applica-
tion has recently been extended to profile entire organisms.
Wong and coworkers have constructed a sialoside microarray
to screen different influenza hemagglutinin (HA) subtypes as
well as complete viruses (Liang et al., 2011; Liao et al., 2010). It
was shown that a minimum of five oligosaccharides are required
todiscriminatedifferent influenza subtypes, includingH1,H3,H5,
H7, and H9. The group also discovered that the entire virus
shared similar pattern with theHA receptor. In another approach,
Bertozzi and coworkers developed a glycopolymer array inwhich
glycans are displayed on a polymer scaffold to mimic native gly-
cans (Godula and Bertozzi, 2012). Different numbers of GalNAc
were introduced to the polymer scaffold via oxime ligation. The
glycopolymer array generated was screened with four fluores-
cently labeled lectins. With this approach, the group was able
to systematically evaluate the effect of molecular composition
and surface density on molecular recognition (Figure 5F). Inter-
estingly, it was found that glycan valency and density can have
a dramatic effect on lectin-ligand interactions. The binding pref-
erences will be affected, resulting in different complex formation.
Microarrays can be employed in epitope mapping and serodi-
agnostic applications as well. Johnston and coworkers devised
a random-sequence peptide microarray to explore antibody
recognition of sequence space (Halperin et al., 2011). The pep-
tide array consists of 10,000 peptide sequences comprising 17
randomized positions. The peptide sequences were generated
randomly in silico, which covers only a small portion of the
theoretical sampling space. Individual antibodies were screened
with this peptide microarray, and subsequently unique peptide-
binding fingerprints were obtained. Subtle antibody-recognition
motifs were discovered. It was shown that this platform can be
used to predict epitopes of monoclonal antibodies but not696 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All righof polyclonal antibodies. Waldmann and coworkers recently
developed a novel glycopeptide microarray to screen serum
antibodies raised against different glycopeptide antigens (West-
erlind et al., 2009). A total of 11 mucin peptides with different
glycosylation patterns were synthesized in this study. New
epitopes were discovered, and the binding patterns of the
antibodies raised against different antigens were shown to be
unique. This method might provide a valuable tool to investigate
antibodies for immunotherapy and immunodiagnostics. To carry
out molecular immune diagnostics, Andresen and coworkers
constructed a peptide array with 54 peptides from a variety of
sources for detecting antibodies in serum (Andresen et al.,
2006). The method proved to be highly sensitive and could
detect picomoles of antibodies in diluted human serum. Using
a peptoid array with 15,000 members, Kodadek and coworkers
successfully identified specific IgG biomarkers for Alzheimer
disease from serum (Reddy et al., 2011). Notably, the group
also uncovered ligands (11; Figure 3) that can pull down specific
antibodies. The method provides a useful tool to discover the
IgG biomarker without knowing the antigens, and it also helps
in developing diagnostic assays for various diseases.
Conclusions
We have witnessed numerous innovative and exciting applica-
tions of microarray technology in proteomics. With the contin-
uous improvement in library design, surface immobilization,
and detection methods, microarray technology has established
itself as an effective tool to advance research in biology and
medicine. Traditional barriers to acquire diverse library collec-
tions have been alleviated by the development of various li-
brary-construction strategies, such as DOS for small molecule
microarray, fragment-based combinatorial synthesis for peptide
microarray, and in situ cell-free synthesis for protein microarray.
Label-free detection techniques with improved sensitivity,
including mass spectrometry and surface plasmon resonance,
have continued to complement the conventional fluorescent
labeling methods. Compared with label-based methods, label-
free methods do not require protein labeling, thereby retaining
the query protein in its native state and minimizing the chance
of interfering with protein functions.
One of the greatest obstacles for microarray to gain wider
popularity in proteomics is the high cost of the instruments and
library resources, which makes the tool inaccessible to many
research groups. The quality of the fabricated microarrays and
the consistency of microarray data are other important factors
that affect the general applicability of this technology. This is
especially problematic for proteinmicroarrays. Despite commer-
cialization by several biotech companies, protein microarrays
remain a tool used only occasionally in academic labs, primarily
due to the cost and more importantly to the unknown functional
state and activity of most proteins immobilized on the chip.
Comparatively, peptide microarrays are much more reliable
and less expensive, and therefore have gained much popularity
among proteomic researchers in recent years. Small molecule
microarrays, on the other hand, have continued to remain a
highly specialized tool, accessible only by select groups of
synthetic chemists who have keen interest in proteomics
research and drug discovery. Looking forward, we believe that
continuous improvement in all facets of microarray technologyts reserved
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make the technology better received by a wider scientific
community and fuel the further expansion of its applications in
proteomics. For example, protein expression array usually
suffers from drawbacks like low protein expression and loss
of protein activity. Incorporation of common standards and
appropriate normalization procedure will help to alleviate the
problem. It is also observed that nonspecific binding could often
introduce false negatives with the microarray technique. By
applying different concentrations of proteins onto the array, the
chance of obtaining false-negative binders can be significantly
reduced. Alternatively, dual labeling of the query protein under
both native and denatured states will also help in identifying
the real binders of the proteins (Uttamchandani et al., 2007b).
Despite the aforementioned challenges and barriers, we are
optimistic that more innovations in microarray technology will
continue in the coming years. The growing number of cloned
genes from various species makes it possible to construct
different types of proteome microarrays and facilitate molecular
interaction network studies across the entire proteome of
different organisms. Development of stereoselective synthesis
that is compatible with solid-phase chemistry will facilitate the
synthesis of a natural-product-like combinatorial library with
the desired stereoisomers and generate more therapeutic leads
for drug discovery. Further development of novel surface immo-
bilization chemistry will continue to improve the throughput and
sensitivity of assays that can be screened on the microarray and
cut down the amount of precious biological/clinical samples.
With the development of nanolithography and imaging tech-
niques, ‘‘nanoarrays’’ with size reduced by several orders of
magnitude may also come to life in the near future. Bioinformat-
ics will also help to overcome the restriction of library size in the
peptide microarray. Through collaboration with clinical scien-
tists, microarray technology could find more medical applica-
tions such as diagnostics and biomarker discovery. Different
types of patient sera and tumor extracts can be directly applied
onto the microarray to obtain their unique fingerprints for diag-
nostic purpose. The unique ligands identified from the array
can be conveniently used to identify the biomarkers underlying
the diseases.
Inaugurated as an analytical tool for proteomics research, the
various forms of microarray technologies, including protein
microarray, peptide microarray, and small molecule microarray,
have gradually evolved into robust platforms to facilitate drug
discovery and diagnostic applications. With the progressive
development and more innovative breakthroughs in the
foreseeable future, microarray technology promises to elevate
its scope of research and potential applications to a higher level.ACKNOWLEDGMENTS
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